Conduent Introduces GenAI Solution for Enhanced FDA Compliance
Conduent Incorporated (Nasdaq: CNDT), a global leader in technology-driven business solutions, announced the launch of a new generative AI-powered platform designed to improve the detection of reportable events. The innovation aims to transform how pharmaceutical and life sciences companies manage compliance with FDA regulations.
The solution, powered by Microsoft Azure OpenAI, enables automated identification of reportable events across all customer communication channels. This approach helps organizations ensure rapid, accurate reporting and maintain regulatory standards with greater efficiency.
About the Collaboration
By combining Conduent’s industry experience with advanced GenAI capabilities, the platform enhances workflow automation and strengthens compliance management within highly regulated sectors.
Contacts
- Media Contact: Sean Collins, Conduent, +1-310-497-9205, [email protected]
- Investor Relations: Joshua Overholt, Conduent, [email protected]
“Powered by Microsoft Azure OpenAI, this solution sets a new benchmark for regulatory precision and operational performance in the life sciences domain.”
Author’s Summary
Conduent’s new AI solution, developed with Microsoft Azure OpenAI, ushers in a new era of automated compliance, improving detection accuracy and reporting speed for FDA-regulated industries.